Preprint Article Version 1 Preserved in Portico This version is not peer-reviewed

Conceptualizing Scaffold Guided Breast Tissue Regeneration in a Preclinical Large Animal Model

Version 1 : Received: 29 April 2024 / Approved: 29 April 2024 / Online: 30 April 2024 (10:12:12 CEST)

How to cite: Cheng, M.; Janzekovic, J.; Finze, R.; Mohseni, M.; Saifzadeh, S.; Ung, O.; Wagels, M.; Hutmacher, D. W. Conceptualizing Scaffold Guided Breast Tissue Regeneration in a Preclinical Large Animal Model. Preprints 2024, 2024041948. https://doi.org/10.20944/preprints202404.1948.v1 Cheng, M.; Janzekovic, J.; Finze, R.; Mohseni, M.; Saifzadeh, S.; Ung, O.; Wagels, M.; Hutmacher, D. W. Conceptualizing Scaffold Guided Breast Tissue Regeneration in a Preclinical Large Animal Model. Preprints 2024, 2024041948. https://doi.org/10.20944/preprints202404.1948.v1

Abstract

Scaffold guided breast tissue regeneration (SGBTR) can both transform reconstructive and cosmetic breast surgery. Implant-based surgery is the most common method. However, there are inherent limitations as there is replacement of tissue rather than regeneration. Regenerating autologous soft tissue has the potential to provide a more like-for-like reconstruction with minimal morbidity. Our SGBTR approach regenerates soft tissue by implanting additively manufactured bioresorbable scaffolds filled with autologous fat graft. A pre-clinical large animal study was conducted implanting 100 ml breast scaffolds (n=55) made from medical-grade polycaprolactone in 11 minipigs for 12 months. Various treatment groups were investigated where immediate or delayed autologous fat graft, as well as platelet rich plasma were added to scaffolds. Computed Tomography and Magnetic Resonance Imaging was performed on explanted scaffolds to determine volume and distribution of regenerated tissue. Histological analysis was performed to confirm tissue type. At 12 months we were able to regenerate and sustain a mean soft tissue volume of 60.9 4.5 ml (95% CI) across all treatment groups. There was no evidence of capsule formation. There were no immediate or long-term post-operative complications. In conclusion, we were able to regenerate clinically relevant soft tissue volumes utilizing SGBTR in a pre-clinical large animal model.

Keywords

Tissue engineering; regenerative medicine; breast reconstruction; scaffold; polycaprolactone; soft tissue; adipose tissue; pre-clinical; large animal; pig

Subject

Medicine and Pharmacology, Surgery

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.